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Abstract.  In healthy adult peripheral  nerve, Schwarm 
cells are believed to be generally quiescent.  Similarly, 
cultures of isolated rat sciatic nerve Schwarm cells 
hardly proliferate in serum-supplemented medium. 
The possibility that Schwann cells negatively regulate 
their own proliferation was supported by the demon- 
stration that conditioned media from Schwann cell cul- 
tures inhibited the proliferation of mitogen-stimulated 
test cultures.  The inhibition could be complete, was 
dose dependent, and was exhibited when the test 
Schwann cells were under the influence of different 
types of mitogens such as cholera toxin,  laminin,  and 
living neurons.  The inhibition of proliferation was 
completely reversible and a rapid doubling of cell 
number resulted when treatment with conditioned 
medium was withdrawn from mitogen-stimulated 
Schwann cells. Conditioned medium from cholera 
toxin-stimulated and immortalized  Schwann cell cul- 
tures contained less antiproliferative activity than that 
found in medium from quiescent Schwann cell cul- 
tures.  However, media conditioned by two actively 
proliferating rat Schwannoma cell lines were rich 
sources of antiproliferative activity for Schwann cells. 
Unlike the mitogen-stimulated Schwann oct.;whose 
proliferation could be inhibited completely, the immor- 
talized and transformed Schwann cell types were 
nearly unresponsive to the antiproliferative activity. 
The antiproliferative activity in Schwann and Schwan- 
noma cell conditioned media was submitted to gel 
filtration and SDS-PAGE. The activity exists in at least 
two distinct forms:  (a) a high molecular weight com- 
plex with an apparent molecular mass >1,000 kD, and 
(b) a lower molecular weight form having a molecular 
mass of 55 kD. The active 55-kD form could be de- 
rived from.the high molecular weight form by gel 
filtration performed under dissociating conditions.  The 
55-kD form was further purified to electrophoretic 
homogeneity. These results suggest that Schwann cells 
produce an autocrine factor, which we designate as a 
"neural antiproliferative protein, which completely in- 
hibits the in vitro proliferation of Schwann cells but 
not that of immortalized  Schwann cells or Schwan- 
noma lines. 
I 
N mammalian peripheral nerve Schwann cell (SC) ~  pro- 
liferation is highly regulated in that it is observed essen- 
tially only during development and after nerve injury. 
During development, SCs recognize and adhere to axons and 
then are stimulated to proliferate and eventually populate the 
entire  length  of the axon (Webster and Favilla,  1984).  In 
healthy adult peripheral nerve SCs generally do not prolifer- 
ate, but they can reenter the mitotic cycle during Wallerian 
degeneration induced by nerve trauma. These same SC be- 
haviors can be reproduced in vitro in that SCs contact and 
adhere  to  neuronal  processes and  then  proliferate  in  re- 
sponse to a neuritic  mitogenic signal  (Salzer  and Bunge, 
1980).  In mature nerve and in established cocultures SCs 
eventually  cease to proliferate even in the continued  pres- 
ence of neurons.  Interestingly,  axonal  fragments  obtained 
from adult nervous tissue and neuronal  cultures  are potent 
mitogens for SCs in vitro (Saizer et al., 1980; DeVries et ai., 
1983). 
1. Abbreviau'ons used in this paper:  APU, antiproliferative units; BrdU, 
bromodeoxyuridine; CM, conditioned medium; NAP, neural antiprolifera- 
tive protein; SC, Schwann cell. 
Unlike most other cell types, isolated rodent SCs prolifer- 
ate very slowly under standard  in vitro conditions  (Wood, 
1976; Manthorpe et al., 1980; Muir et al., 1989a).  In addi- 
tion to the neuritic mitogen, a limited array of soluble agents 
stimulate  the proliferation  of cultured SCs (for review  see 
Ratner et al., 1986), such as glial growth factor (Brockes et 
al.,  1979),  glial  maturation  factor  (Bosch et al.,  1984), 
transforming  growth factor-B (Ridley et al., 1989), laminin, 
and fibronectin  (McGarvey et al.,  1984), as well as agents 
such as cholera toxin and dibutyryl cAMP that raise intracel- 
lular cAMP levels (Brockes et ai., 1979). In addition,  several 
autocrine mitogens have been postulated for SCs including 
the SC basal lamina component laminin  (McGarvey et al., 
1984; Dziadek et al.,  1986), glial maturation factor (Bosch 
et ai., 1984; Lim et al., 1988), transforming growth factor-/3 
(Ridley et al.,  1989),  and an activity reported in medium 
conditioned by primary and immortalized SCs (Porter et ai., 
1987). Thus, even though cultured SCs can produce a num- 
ber of potential  autocrine mitogens,  they remain virtually 
quiescent even in high cell density, long-term cultures. 
Transplacentai  induction of rat tumors with the carcinogen 
©  The Rockefeller University Press, 0021-9525/90/12/2663/9  $2.00 
The Journal of  Cell Biology, Volume 1  ! 1 (No. 6, Pt. 1), Dec. 1990 2663-2671  2663 ethylnitrosourea has yielded several Schwannoma cell lines, 
and  the  RN22  (Pfeiffer and Wechsler,  1972)  and  D6P2T 
(Bansal and Pfeiffer, 1987) clonal lines have been used exten- 
sively for the study of SC biology. Transformed SCs express- 
ing the oncogenes SV-40 large T and v-Ha-ras (Ridley et al., 
1988) can proliferate in the absence of added mitogens.  In 
addition, Porter and co-workers (1987) describe an immor- 
talization of rat sciatic nerve SCs without the use of viral in- 
fection, oncogene transformation,  or chemical carcinogens. 
They found that  primary  SC cultures,  expanded  continu- 
ously with a combination of glial growth factor and forsko- 
lin, eventually yielded a population of cells that continue to 
proliferate in the absence of exogenous mitogens. Similarly, 
we have generated by long-term exposure to cholera toxin an 
immortalized line of rat sciatic nerve SCs that continuously 
divide (unpublished observation). All of the above SC lines 
provide in vitro models for studies of the regulation of SC 
proliferation. 
The mechanisms underlying the cessation of SC prolifera- 
tion in the developing nerve and in vitro are obscure. A virtu- 
ally unexplored possibility is that SC proliferation is regu- 
lated by inhibitory signals. Here we provide evidence that SC 
proliferation in vitro is under negative autocrine regulation. 
We  developed and  used  an  in  vitro  microplate  assay  of 
bromodeoxyuridine  (BrdU)  incorporation  into  DNA  to 
quantify and monitor this antiproliferative activity after vari- 
ous treatments and during fractionations.  We have isolated 
from conditioned media (CM) a 55-kD protein,  which we 
have termed neural antiproliferative protein or NAP, that in- 
hibits DNA synthesis by mitogen-stimulated  SCs. 
Materials and Methods 
Cell Culture 
Purified populations of quiescent SCs were obtained from dissociated neo- 
natal rat sciatic nerves as previously described (Muir et al., 1989a). Dense 
(but subconfluent) SC cultures (3-4 x  10  ~ cells/100-mm dish) were grown 
in Dulbecco's modification of Eagle's medium supplemented with penicillin 
and L-glutamine (1 raM) (DME) containing 2 or 10% calf serum, and CM 
was collected every 2 d. Loss of normal growth control (immortalization) 
of secondary SCs was achieved by continuous treatment with 20 ng/ml chol- 
era toxin (Sigma Chemical Co., St. Louis, MO) and passaging 1:6 every 
4 d for 2-3 too. The immortalized SCs were further passaged 1:10 every 
5 d for 1-2 rno without cholera toxin. RN22 (Pfeiffer and Wechsler, 1972) 
and D6F2T Schwannoma cells (Bansal and Pfeiffer, 1987) were cultured in 
DME containing 10% calf serum. For the collection of serum-free RN22 
CM, dense (3-4 ×  106 cells/100-mm dish) cultures were rinsed t~.,.  ice with 
PBS to remove serum proteins and the cells were grown in serum-free DME 
for 2 d before medium collection. Serum-containing and serum-free CM 
were also collected from rat brain astroglia (prepared according to Rudge et 
al., 1985),  oligodendroglia (McCarthy and de Vellis,  1980),  sciatic nerve, 
and mouse 3T3  fibroblasts. Cells were determined to be free of myco- 
plasma. 
SC Proliferation Assay and Immunostaining 
Quiescent SC microcultures were established in polyornithine-trnatad, 96- 
well plates containing 14,000 cells/6-mm well in 100 #l of DME  +  10% 
calf serum as described (Muir et al.,  1989a).  For some assays $Cs were 
seeded in polyomithine-coated  wells treatted with 50 #1 ofa 2 #g/ml solution 
of rat L2 yolk sac tumor laminin (prepared as described by Engvall et al., 
1983).  SC/neuron cocultures were established by adding 14,000 SCs and 
2,000 embryonic day 8 ciliary ganglionic motor neurons to each microwell 
as described (Muir et al., 1989a). For routine assays of antiproliferative ac- 
tivity on mitogen-stimulated SCs, microcultures were seeded in DME  + 
10%  calf serum containing 20 ng/mi cholera toxin. Serially diluted test 
samples were presented for 72 h and BrdU (Sigma Chemical Co.) was added 
tO a concentration of 1 #M during the final 24 h. SC proliferation wasas- 
sessed by direct cell counting and BrdU incorporation into DNA was mea- 
sured by an ELISA performed on fixed monolayer microcultures as previ- 
ously described (Muir et al., 1990).  Briefly, after BrdU incorporation the 
cells were fixed by 70% ethanol and the DNA was denatured by incubation 
with 2 M HC1 for 10 min at 37°C. BrdU-DNA was labeled using monoclo- 
nal anti-BrdU antibody (50 #l/well, 1 #g/ml; Dako-Patts Corp., Santa Bar- 
bara, CA) and bound antibody was detected by peroxidase-conjugeted  rab- 
bit  anti-mouse  IgG  (50  #l/well,  2  #g/ml;  Dako-Patts  Corp.).  The 
colorimetric substrates o-phenylenediamine (0.05 %) and  H202  (0.02 %) 
were added in 50 mM phosphate/citrate buffer at pH 5 and the reaction was 
terminated after 5-20 rain by the addition of sulfuric acid. The absorbance 
was measured at 490 nm by a microplate reader (model MR600; Dynatech 
Laboratories,  Inc.,  Alexandria, VA) interfaced with a  computer.  Using 
cholera toxin-stimulated SCs, the titer of each sample in antiproliferative 
units (APU) per milliliter was expressed as the sample dilution required to 
inhibit by 50% themaximal incorporation of BrdU into DNA (BrdU-DNA 
immunoactivity). The pementage of cells with BrdU-DNA was determined 
by immunostalning essentially as described above in the ELISA except that 
the insoluble chromagen diaminobenzedine-tetrahydrochloride was used. 
Proliferation assays using immortalized SC and rat Schwannoma cell lines 
were performed as described above for SCs except that no mitogens were 
added to the serum-supplemented medium. 
Fractionation of CM 
Medium conditioned by SCs Or RN22 Schwannoma cells was filtered (0.2- 
#m pore). The CM was concentrated by ultrafiltration using a 10-kD cut-off 
filter (model YM10; Amicon CÙrp., Danvers, M_A) and then dialyzed with 
PBS.  The CM concentrate was fractionated by CLAB  (Pharmacia Fine 
Chemicals, Piscataway,  NJ) gel filtration (2.5  x  96-cm column) in PBS. 
The fractions were assayed for antipmlifemtive activity on SCs as described 
above. Active fractions were later concentrated using centricon filtration 
(10-kD  cut-off; Amicon Corp.). An active high molecular weight fraction 
was made 4  M with urea and refractionated on the CL4B column as de- 
scribed above. 
To purify and characterize a lower molecular mass form (55 kD) of the 
antiproliferative activity, CM was fractionated by ion-exchange chromatog- 
raphy using a DEAE-cellulose (Whatman Inc., Hillsboro, OR) column (2 
×  10 cm) equilibrated with 150 mM NaCI/10 mM sodium phosphate buffer, 
pH 8.0. 500 ml CM was applied to the column and the bound material was 
eluted by  a  linear NaCI  gradient (0.15-1.0  M).  The  active nonbinding 
effluent was filtered through a  100-kD filter (YM100; Amicon Corp.) and 
then the filtrate was concentrated by a YM10 filter and dialyzed with PBS. 
The concentrate was further fractionated by CIAB (Pharmacia Fine Chemi- 
cals) gel filtration (2.5 ×  96 cm) in PBS. Molecular weight estimation was 
also performed using an $200 (superfine; Pharmacia Fine Chemicals) gel 
filtration column (1.0 ×  150 cm)xequilibrated with PBS. 
SDS-PAGE 
SDS-PAGE was carried out according to the procedure of Laemmli (1970), 
using 12% acrylamide gels under nonreducing conditions. CM-derivad ac- 
tive fractions were electroph0resed  at 4°C and then the gel was washed thor- 
oughly with 2.5% Triton X-100 to remove SDS and with PBS to remove 
the Triton. The gel was then cut horizontally into 2.5-ram slices and the 
slices were minced. The proteins were eluted by diffusion into PBS, the 
pieces were removed by centrifugation, and the supernatants were dialyzed 
with PBS and then assayed for antiproliferative activity. The active samples 
were rerun on SDS gels and then electroblotted to nitrocellulose sheets ac- 
cording to the methods of Towbin et al. (1979).  The sheets were stained for 
protein using colloidal gold (Aurodye forte; Janssen Life Sciences Products, 
Piscataway,  NJ). 
Metabolic Labeling with tOJS]Methionine 
Protein synthesis by SCs in vitro was quantified by the incorporation of ra- 
diolabeled amino  acids.  Quiescent SCs  were  cultured  in  DME  (98% 
methionine-free DME +  2% DME) containing 10% dialyzed calf serum 
and 10 ~Ci/ml Trans3~S-label  (ICN Biochemicals, Inc., Irvine, CA) in the 
absence and presence of CM or fractions containing antiproliferative activ- 
ity. After 72 h the cultures were washed several times with Hank's balanced 
salt solution, hydrolyzed with 0.2 N NaOH at 37°C for 30 rain, and then 
mixed with Liquiscint (National Diagnostics, Inc.,  Somerville, NJ)  and 
counted. 
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Figure 1.  Schwann cell pro- 
liferation in response to chol- 
era toxin and medium  changes. 
SC cultures (20,000 cells/cm  2) 
were treated for 3 d with 20 
ng/ml cholera toxin in DME 
containing  10%  calf serum 
without changing the medium 
and then the medium was re- 
moved and the cultures were 
grown for the next 3 d in I part 
DME containing 10% calf se- 
rum and 3 parts saline. Cell 
proliferation was examined in 
replicate cultures by the addition of 1 t~M BrdU to the culture 
medium for 24-h periods throughout the 6-d experiment. After 
each 24-h period the assay was terminated by ethanol fixation and 
the cells were immunostained for BrdU incorporation into DNA as 
described in Materials and Methods. Data represent the mean of 
four determinations (50 cells each) per dish and each condition was 
duplicated in each of two separate experiments. (SD <  8%). 
Results 
Growth Properties of Neonatal Rat Sciatic Nerve SCs 
To generate large numbers of cells, we typically expand the 
primary SCs in the presence of cholera toxin as mitogen 
(Muir et al., 1989a). We noticed during such cell expansions 
that the SC number per culture and BrdU incorporation ap- 
peared to increase mostly within the first day after each 
medium change. By 3-4 d after each medium change the cell 
number stabilized and DNA synthesis decreased until the 
next medium change caused another rapid burst of prolifera- 
tion.  The decreased rate of proliferation could be due to 
depletion of mitogen (i.e.,  cholera toxin) or depletion of 
medium nutrients (e.g., vitamins, amino acids, etc.), or to 
the accumulation within the culture medium of substances 
that inhibit SC proliferation. Similarly, restoring the mito- 
gen and medium or removing CM could result in the burst 
of proliferation. To address these possibilities we monitored 
BrdU incorporation over 1-d intervals after selected medium 
changes. The results are shown in Fig.  1. After treatment 
with medium containing cholera toxin mitogen the percent 
of  BrdU-labeled cells rose to '~50% but then declined by day 
3 to 20%  (Fig.  1, closed  circles).  When the medium was 
changed either to medium with cholera toxin or to fresh 
medium alone (data not shown), or even to medium alone 
diluted to 25 % in saline (Fig. 1, open circles), cell prolifera- 
tion rose again to the 50% level before declining to the 20% 
level. This propensity of mitogen-stimulated SCs to resume 
proliferation even in a mitogen-free, nutrient-diluted media 
suggested that these  cells  remained under the mitogenic 
influence of previously applied cholera toxin and under the 
supportive influence of the media supplement. These data 
also support the notion that antiproliferative substances may 
accumulate within SC cultures and that treatments decreas- 
ing such an accumulation (i.e., medium changes) will once 
again permit the cells to respond to mitogens. 
SC Response to Mitogens and Inhibition by SC CM 
To detect and measure the activity of putative antiprolifera- 
rive substances, we used a modification  of  our ELISA-irnmu- 
nostaining method for quantifying BrdU incorporation (Muir 
et al., 1990).  Replicate SC microcultures were set up in the 
presence of three distinct SC mitogens, each of which we 
previously showed to elicit different maximal levels of BrdU 
incorporation into DNA (Muir et al.,  1989a).  Compared 
with untreated SCs, BrdU immunoactivity  was increased 35- 
fold by cholera toxin (20 ng/ml), 2-fold by substratum-bound 
laminin (20 ~g/ml), and  16-fold by chick ciliary neurons 
(2,000 cells/well). Each of these mitogen-stimulated SC mi- 
crocultures was then treated with serial dilutions of CM col- 
lected for 2-4 d from dense, virtually quiescent SC cultures. 
BrdU incorporation into DNA was measured and expressed 
as the percent of BrdU-DNA immunoactivity achieved by 
SCs stimulated with a maximal dose of the corresponding 
mitogen alone. The results are shown in Fig. 2 A. SC CM 
appeared to possess about the same inhibitory titer (10 APU/ 
ml) against all three mitogens and 90 % inhibition was ob- 
tained with 50%  SC CM. Virtually complete inhibition of 
BrdU incorporation could be obtained using 10-fold concen- 
trated SC CM at a  10-fold  dilution (not shown).  Similar 
results were obtained using SC CM dialyzed with culture 
medium, indicating that the antiproliferative activity was not 
due to low molecular weight toxins or medium depletion 
effects. To test for antiproliferative activity in CM and during 
CM fractionations we routinely used cholera toxin-stimu- 
lated SC microcultures and quantified BrdU incorporation 
by ELISA. Results from these assays were confirmed by im- 
munostalning the treated microcultures for BrdU and count- 
ing the percentage of labeled nuclei by microscopy. In the 
presence  of cholera toxin ,~,40% of the cells had BrdU- 
labeled nuclei (Fig. 2 B), and treatment of cholera toxin- 
stimulated cultures with 50% SC CM reduced this labeling 
to <4% (Fig. 2 C). SC CM similarly inhibited SC prolifera- 
tion in response to other mitogens such as dibutyryl cAMP, 
fibronectin, rat brain axolemmal fragments (DeVries et al., 
1983), and peripheral neuron extracts (Salzer et al., 1980a) 
(results not shown). At very high CM dilutions (1:60-1:120) 
the extent of BrdU  immunoactivity slightly exceeded the 
maximal BrdU immunoactivity achieved by mitogen alone, 
suggesting that SC CM might possess an additive mitogenic 
activity that is masked by the inhibitory activity. 
Next we used the BrdU assay to confirm our earlier obser- 
vation (cf. Fig. 1) that the SC CM-induced inhibition of SC 
proliferation is reversible. The mitogenic effects of cholera 
toxin, laminin, and neurons toward untreated or CM-treated 
SCs over a 4-d period were first examined. The results are 
shown in Fig. 3 (solid circles). Both cholera toxin (Fig. 3 A) 
and laminin (Fig. 3 B) increased SC DNA synthesis over the 
first 2 d, followed by a gradual decline. Neurons increased 
SC DNA synthesis to reach a maximum by the second day, 
after which DNA synthesis sharply declined (Fig. 3 C). In 
the presence of  each mitogen, continuous C M treatment sup- 
pressed most SC DNA synthesis over the 4-d test period 
(Fig. 3, solid triangles).  To examine the reversibility of the 
inhibitory activity, SC CM treatment of mitogen-stimulated 
cultures was discontinued on day 2 and BrdU incorporation 
was assayed at 24-h intervals thereafter. The data are shown 
in Fig. 3 (open triangles).  A near complete recovery of SC 
proliferation was observed within 48 h of withdrawal of CM 
for SCs stimulated by laminin (Fig. 3 B) and within 24 h for 
those stimulated by neurons (Fig. 3 C) or cholera toxin (Fig. 
Muir et al. Schwann Cell Proliferation under Negative Autocrine Control  2665 Figure 2. Schwann cell response to mitogens and inhibition by Schwann cell CM. Subconituent microcultures  of rat sciatic nerve SCs 
(14,000 cells/6-mm-diam  well) were grown with  100 #1 DME containing  10% calf serum with one of the following mitogens:  soluble 
cholera toxin (20 ng/ml); polyornithine-treated wells coated with rat laminin (50/~l/well,  2 #g/ml), or coculture with ciliary ganglionic 
neurons (2,000 neurons/well).  These mitogen-stimulated SCs were treated for 72 h with serial dilutions of CM from dense SC cultures. 
SC proliferation was assessed by addition of 1/zM BrdU to the media during the final 24 h and immtmoassay of BrdU incorporation into 
DNA (A) and immunostaining of BrdU-labeled nuclei (B, C) were performed as described  in Materials  and Methods.  Values for each 
condition in A were expressed as the percentage of mitogen-stimulated [BrdU]DNA immunoaetivity for the corresponding mitogen without 
SC CM treatment. For cholera toxin-stimulated  cultures (B) and cholera toxin-stimulated  cultures treated with 50% SC CM (C), BrdU- 
labeled nuclei were immunostained using diaminobenzedine-tetrahydrochloride and unlabeled nuclei were lightly counterstained with tolu- 
idine blue. Data represent the means of quadruplicate determinations from four separate experiments. Cholera toxin and laminin,  SD < 
6%; neurons,  SD <  16%). 
3 A). For laminin-stimulated SCs, the kinetics of recovery 
after withdrawal  of the  antiproliferative activity appeared 
similar to the initial BrdU incorporation into DNA in re- 
sponse to  laminin.  However, cholera  toxin-  and  neuron- 
treated SCs showed a  more rapid burst of DNA synthesis 
(Fig. 3; compare plots of solid circles with those of open tri- 
angles). 
Inhibition of cell proliferation might result from direct in- 
hibition or downregulation of DNA synthesis, but may also 
result from various metabolic impairments that  indirectly 
hinder  mitotic  activity.  In vitro culture  medium may ac- 
cumulate  cellular excretions,  which  then become concen- 
trated  during  fractionations.  Exclusion  of low  molecular 
weight  metabolites  from  antiproliferative  samples  by  ul- 
trafiltration, dialysis, or gel filtrations did not diminish the 
antiproliferative activity (not shown).  To examine whether 
the antiproliferative activity impaired cellular metabolism, 
SCs and SCs treated with antiproliferative CM and fractions 
(see  below)  were  cultured  for  3  d  (the  duration  of the 
proliferation assays) in the presence of radiolabeled methio- 
nine.  If anything,  cellular  [3sS]methionine  incorporation 
was actually increased slightly (to  105-120%  of untreated 
controls)  by  treatment  with  the  antiproliferative  activity. 
Thus we conclude that the antiproliferative factor is not cyto- 
toxic. 
Comparison of Different Sources of 
Antiproliferative Activity 
To survey the distribution of antiproliferative activity and to 
choose a plentiful source for its further characterization, we 
measured the amount of antiproliferative activity toward SC 
in selected cell-conditioned media. Different source cultures 
were set up under identical conditions (culture vessel size, 
media, volume, cell density) and culture media were condi- 
tioned for 2 d before being assayed for antiproliferative activ- 
ity toward test SC microcultures. The results are shown in 
Table I. Antiproliferative activity was detectable in all of the 
SC-related CM (primary, immortalized, transformed cells) 
but was absent in CM  from central glial cells (astroglia, 
oligodendroglia),  brain  meningeal,  31"3, or  sciatic  nerve 
fibroblast cells. We chose the rat RN22 Schwannoma cells 
to be our preferred source of anfiproliferative activity since 
these cells (a) produce a reasonably high amount of activity 
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Figure 3.  Reversibility of the 
antiproliferative  activity.  SC 
microcultures were treated with 
cholera toxin (A), laminin (B), 
or ciliary neurons (C), as de- 
scribed in Fig. 2. BrdU incor- 
poration  in response  to each 
mitogen was examined over a 
4- or 5-d period (solid circles). 
A second set of mitogen-stim- 
dated SC cultures was treated 
with SC CM (a 1:10 dilution 
of SC  CM that  was concen- 
trated  10-fold and  dialyzed) 
from the  onset  of the  assays 
(closed triangles). A third set 
of replicate cultures ~  treated 
with SC CM (as above) from 
the onset of the assays except 
that at 2 d the treatment medi- 
um was removed and replaced 
with fresh, unconditioned me- 
dium (open triangles). BrdU 
was  added  during  the  final 
24 h of each test interval (days 
0-1,  0-2, 0-3,  and 0--4, and 
for neurons 0-5) and the as- 
says were terminated by etha- 
nol fixation. [BrdU-]DNA  was 
measured  by ELISA and irn- 
munoreactivity was expressed 
as a percent of the maximum  value obtained for each mitogen. Data 
represent the means of two experiments each having quadruplicate 
determinations.  A and B, SD <  8%; C, SD <  14%). 
Table I. Antiproliferative Activity toward Schwann Cells: 
Comparison of Conditioned Media from Different Sources 
Source  Mitotic cycle  APU/ml  per 10  ~ cells 
d 
SC  16  5.1 
SC  +CTx  2-3  1.9 
Immortal SC  2  1.2 
RN22 (+ serum)  0.8  6.8 
RN22  (serum-free)  1-2  2.6 
D6P2T  0.7  7.3 
Astroglia  ND  <0.1 
Oligodendroglia  ND  <0.1 
Meningeal cells  ND  <0.1 
Fibroblasts (nerve)  ND  <0.1 
3T3  fibroblasts  ND  <0.1 
Cells in logarithmic growth were detached and dissociated by trypsin/EDTA 
and then 2  x  10  ~ cells were seeded in 75-cm  2 tissue culture dishes. The cul- 
tures were grown in DME supplemented with 10% calf serum and after 24 h 
the cells were counted (by phase microscopy) and the medium was replaced 
with  10 ml of DME supplemented with 2%  calf serum (or DME only  for 
serum-free RN22). The cultures were grown for 48 h and then the cells were 
counted and the CM was collected. SC + CTx cells were treated with 20 ng/ml 
of cholera toxin for 2 d before and 24 h after seeding in the  100-ram dishes. 
The effects of cholera toxin on SC proliferation persist for at least 2 d after its 
removal from SC cultures.  During the 48-h CM collection period,  SC +  CTx 
medium did not contain cholera toxin, although a high rate of cell division con- 
tinued. The CMs were assayed for the ability to inhibit incorporation of BrdU 
into DNA by mitogen-stimulated SCs as described in Materials and Methods. 
The titer of each CM was expressed as antiproliferative units per milliliter of 
CM and normalized to an average cell number (the mean of initial and ending 
cell numbers) present during the 48-h CM collection period. Data represent the 
means of eight determinations from four separate CM collection experiments 
(SD <  10%). 
per ceil; (b) are more readily available due to a faster rate 
of doubling; and (c) can be cultured for an extended period 
in serum-free medium, allowing the activity to be more high- 
ly concentrated by ultra_filtration  and relatively low in serum 
contaminants. Most of the following studies were carried out 
using serum-free RN22 CM.  However, certain key experi- 
ments performed on the RN22 serum-free CM were repli- 
cated using the serum-containing CM from rat nerve SCs. 
Comparison of  Antiproliferative Activity toward 
Normal and Transformed SCs 
Table I also shows that cellular antiproliferative activity out- 
put into the media is apparently lower when the SCs are ac- 
tively proliferating, such as under cholera toxin stimulation 
(SC  +  CTx) or after immortalization (immortal SC). How- 
ever, transformed SCs such as the Schwannorna cell lines 
(RN22, D6P2T) actively proliferate (i.e., have a very short 
doubling  time)  and  still  produce  a  high  amount  of an- 
tiproliferative activity. This suggests that the Schwannoma 
cells have lost their responsiveness to inhibition by the anti- 
proliferative activity. To compare the responsiveness of the 
different SC  types,  we presented concentrated  serum-free 
RN22 CM to cholera toxin-stimulated primary SCs, immor- 
talized SCs, and the Schwannorna ceils, all under otherwise 
identical culture conditions. The results are shown in Fig. 4. 
DNA synthesis by cholera toxin-stimulated  SCs could be 
completely inhibited,  whereas  that by immortalized SCs, 
RN22, and D6P2T Schwannoma cells could be inhibited by 
only ,~40,  30,  and 20 %, respectively. Similar results were 
obtained for each cell type using CM from normal SCs (not 
shown). These findings indicate that transformed SCs are, at 
best,  only  partially  responsive  to  inhibition  by  the  an- 
tiproliferative activity,  and the  more rapidly proliferating 
cells are the least responsive. 
Isolation and Partial Characterization of the 
Antiproliferative Factor 
We submitted SC CM and serum-free RN22 CM to several 
biochemical fractionation steps and monitored the recovery 
100 
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D6P2T 
100  1000  10000 
Serum-free  fiN22  CM  (300x)  (fold  dilution) 
Figure 4.  Responsiveness  of 
transformed  SC  types to the 
antiproliferative activity. SCs 
treated with cholera toxin (20 
ng/ml),  immortalized  SCs, 
and RN22 and DtP2I" Schwan- 
noma cells  were cultured  in 
microwells (14,000 cells/well) 
and treated for 72 h with serial 
dilutions of serum-free RN22 
CM  (concentrated  300-fold) 
BrdU was added to the micro- 
cultures for the final 24 h and 
[BrdU)DNA was measured  by ELISA.  Data represent  immuno- 
reactivity expressed as a percent of the maximum value obtained 
for each actively proliferating cell type. SD < 4%. 
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Figure 5. Fractionation  of SC CM and serum-free RN22 CM by 
CL4B gel filtration. In A, 150 ml of SC CM was concentrated 30- 
fold by ultrafiltration (10 kD cut-off), dialyzed with PBS, and then 
ehited from a CL4B gel filtration column in the same buffer. B, 
Similarly, 1,500 ml of serum-free RN22 CM was concentrated 300- 
fold by ultrafiltration,  dialyzed, and analyzed by CL4B gel filtra- 
tion. 8-ml fractions were collected and assayed for antiproliferative 
activity. The titers were expressed in antiproliferative units/milli- 
liter as described in Materials and Methods. All titrations were per- 
formed in duplicate and four determinations  were made from two 
separate  fractionations.  A and B,  SD <  5 %.  Several molecular 
weight markers were used and the elution of ovalbumin (45 kD) is 
shown. Vo indicates the high molecular weight (>1,000 kD) void 
volume and Vt indicates the total column volume. 
of antiproliferative  activity  in  the  derived  fractions.  The 
CMs were first concentrated by ultrafiltration and then frac- 
tionated by CL4B gel filtration. The elution profile for SC 
CM (30x concentrated) is shown in Fig. 5 A and for serum- 
free RN22 CM (300x  concentrated) in Fig. 5 B.  For both 
CMs, three distinct peaks of activity eluted from the column 
in regions corresponding in molecular masses of >1,000 kD 
(void volume, ~), 45-55 kD, and <30 kD (total volume, Vt). 
For a sample of SC CM containing 1,500 APU (10 APU/mg; 
5 ml of 30x concentrated CM), ,,o25%  of the recovered ac- 
tivity eluted in the high molecular weight void volume, 50 % 
in the 45-55-kD fractions, and 20% in the total volume frac- 
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Figure 6. Isolation of  the 55-kD antiproliferative factor. SC CM (A) 
and serum-free  RN22 CM (B) were applied to a DEAE ion ex- 
change column and the flow-through was submitted to ultrafikration 
using a 100-kD cut-off filter (to remove any residual high molecular 
weight material). The filtrate was concentrated and then examined 
by CL4B gel filtration. The ehition of antiproliferative activity was 
determined  as described  in Fig. 5. 
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Figure 7. Dissociation of the 55-kD antiproliferative factor from the 
high molecular weight complexed form. The high molecular weight 
void volume fractions  (180-204  ml) from CL4B gel filtration of 
serum-free RN22 CM (cf. Fig. 5 B) were pooled,  concentrated, 
and then dialyzed with 4 M urea in PBS. The dissociated sample 
was submitted a second time to CL4B gel filtration and was eluted 
with PBS. 8-ml fractions were collected and assayed for antipro- 
liferative activity. Fractions containing urea, which eluted in the 
column Vt, were dialyzed with PBS before they were assayed. The 
titers were expressed in antiproliferative units/milliliter as described 
in Materials and Methods. All titrations were performed in dupli- 
cate and four determinations were made from two separate fraction- 
ations. SD < 8 %. Several molecular weight markers were used and 
the elution of ovalbumin (45 kD) is shown. Vo indicates the high 
molecular weight (>1,000 kD) void volume and Vt indicates the to- 
tal column volume. 
tions; 5% of the activity was unaccounted for. The highest 
specific activity of 28 APU/mg total protein was found in 
fractions eluting in ,,o420 ml, which corresponded to a mo- 
lecular mass between 45 and 55 kD (Fig. 5 A). For a serum- 
free RN22  CM sample containing 7,500 APU (380 APU/ 
mg; 5 ml of 300x concentrated CM), 50% of the recovered 
activity eluted in the high molecular mass void volume, 30% 
in the fractions corresponding to 45-55 kD, and 5 % in the 
total volume fractions; 20% of the activity was unaccounted 
for. The highest specific activity of 800 APU/mg was found 
in fractions eluting in •420  ml, which corresponded to a 
molecular mass between 45 and 55 kD. 
We attempted to isolate the 55-kD antiproliferative factor 
by DEAE ion exchange fraetionation ofSC CM (10 APUIml, 
7 APU/mg). Most of the inhibitory activity flowed through 
a DEAE column at pH 8, and the total inhibitory activity of 
the nonbinding effluent was increased almost twofold and the 
specific activity more than  14-fold.  In addition to this in- 
creased recovery of flow-through activity, ~25 % of the ap- 
plied  activity bound  to  and  could be recovered from the 
column. Gel filtration of the recovered DEAE-binding mate- 
rial indicated that only the high molecular weight form of the 
activity  binds  to  DEAE  (data  not  shown).  The  DEAE- 
binding activity was eluted by low ionic condition (<0.25 M 
NaCI), indicating that this activity was not attributed to pro- 
teoglycans, which typically are eluted by stronger ionic con- 
ditions.  The  DEAE  flow-through  was  submitted  to  ul- 
traliltration  using  a  100-kD  cut-off filter  (to remove any 
residual high molecular weight material) and then the filtrate 
was submitted to CL4B gel filtration. The results are shown 
in Fig. 6 A. Antiproliferative activity emerged as one sharp 
peak in a region corresponding to a molecular mass of *55 
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was  recovered  in  the  peak  fractions  (elution  volume  = 
416--432 ml) with a 28-fold purification (200 APU/mg). 
Serum-free rat RN22 Schwannoma cell CM was submitted 
to the same fractionation steps just described. The starting 
serum-free RN22 CM contained about one-half the titer of 
the antiproliferative activity in SC medium, but >50 times 
the specific activity (380 APU/mg). The titer of the DEAE 
nonbinding fraction was  slightly greater  than that of the 
loaded serum-free RN22 CM even though >40% of that ac- 
tivity bound to and could be eluted from the DEAE column. 
The DEAE nonbinding fraction was passed through a  100- 
kD cut-off  filter, concentrated, and then examined by CL4B 
gel filtration. The results are shown in Fig. 6 B.  The an- 
tiproliferative activity eluted with 416-424  ml in a  single 
sharp peak which had a specific activity >40,000 APU/mg, 
representing 20%  recovery and 100-fold  purification com- 
pared with the crude CM. 
Next we examined the properties of the high molecular 
weight activity from the first CL4B fractionation (cf. Fig. 5). 
The void volume (Vo) fractions (180-204 ml; 3,000 APU to- 
tal, 200 APU/mg) obtained from RN22 CM shown in Fig. 
5 B were brought to 4 M urea and further fractionated by a 
second CL4B gel filtration column equilibrated with PBS. 
The results are shown in Fig. 7. The eluted fractions were 
assayed for antiproliferative activity and fractions containing 
urea, which eluted with •500  mi (Vt), were dialyzed with 
PBS before they were assayed. Activity eluted in two major 
peaks having molecular masses similar to those observed for 
CM in the first gel filtration step (cf. Fig. 5 B). Only the high 
molecular mass peak was observed if  the sample was submit- 
ted to gel filtration without urea dissociation (results not 
shown).  Apparently  the  high  molecular  weight  material 
could be at least partially dissociated by urea to release the 
55-kD form of  the activity. The 55-kD fraction (416-424 ml) 
had  a  specific  activity of 300,000  APU/mg,  which  cor- 
responded to an 800-fold purification. Interestingly, the total 
activity recovered from the CL4B column (including both 
the 1,000- and 55-kD peaks) was 1.5 times greater than the 
loaded activity, suggesting either that NAP was activated by 
dissociative conditions or that an inhibitor was removed. The 
purified 55-kD factor, termed NAP, elicited 50% inhibition 
of  total BrdU incorporation at 65 pM. Treatment of  mitogen- 
stimulated SCs with 3.5 ng/mi of purified NAP reduced the 
percentage of BrdU-labeled nuclei from 40 (+5) to 20 (+4) 
and 20 ng/mi essentially reduced the percentage to zero. 
The high molecular weight fraction from gel filtration of 
the serum-free RN22 CM was also examined by SDS-PAGE 
and gel slices were extracted and assayed for antiproliferative 
activity. The results are shown in Fig. 8. Antiproliferative 
activity was essentially extracted from a single gel slice cor- 
responding to the molecular weight region 55 kD. While the 
high molecular weight form of the activity apparently did 
not enter the gel, the dissociative conditions (SDS) released 
a  significant amount of the active 55-kD NAP.  The active 
material that eluted from the preparative SDS gel was exam- 
ined by analytical SDS-PAGE,  electrobloaing, and colloidal 
gold staining. The results showed that this preparation of 
the 55-kD  antiproliferative factor was  electrophoreticaUy 
pure (Fig. 9). The activity of this purified 55-kD NAP was 
greatly diminished by heat (90°C, 20 rain), NaOH hydroly- 
sis, and digestion with pronase. These properties suggest that 
Figure 8. Purification of  the 55-kD antiproliferative  factor by SDS- 
PAGE. The high molecular weight void volume fractions (180-204 
ml) from CIAB gel filtration of serum-free RN22 CM (of. Fig. 5 
B) were pooled and concentrated. The sample was dissociated with 
SDS  and  electrophoresed under  nonreducing conditions on  a 
preparative 8  % acrylamide gel. The gel was washed  to remove  SDS 
and then cut horizontally into 2.5-mm slices. The proteins were 
eluted from the slices and then assayed  for antiproliferative  activity. 
The active fractions were rerun on analytic SDS gels and then elec- 
troblotted to mtrocellulose sheets that were stained for protein 
using colloidal gold. Molecular weight markers were albumin (67 
kD) and ovalbumin (45 kD). 
the antiproliferative activity toward SCs resides in a 55-kD 
protein. 
Discussion 
Our in vitro observations indicate that SCs contribute sig- 
nificantly to the regulation of their own proliferation by re- 
leasing an autocrine antiproliferative factor that can override 
stimulation  by neurons and all other tested mitogens. The an- 
tiproliferative activity in CM occurs in two molecular forms 
separable during fractionations, a  55-kD form and a high 
molecular weight form with which part of the 55-kD form 
may be associated. Although it was possible to sequester the 
55-kD NAP from solution using immobilized high molecu- 
lar weight material (Iio,  Fig. 7) (unpublished observation), 
we have not yet determined the nature of this association or 
to which component in the high molecular weight material 
the 55-kD NAP was bound. Even after dissociation and sep- 
aration of the 55-kD fraction (cf. Fig. 7) much of the anti- 
proliferative actiVity continued to be expressed in a high mo- 
lecular mass form. Possibly the complex was only partially 
dissociated in 4 M urea, or alternatively, the high molecular 
mass complexes might contain two different antiproliferative 
factors, a high molecular weight substance and the 55-kD 
NAP. Some characterized components of the high molecular 
weight fraction are known to be mitogenic for cultured SCs 
(e.g., laminin and fibronectin). Proteoglycans are possible 
candidates for being high molecular weight inhibitors and re- 
cently Yamaguchi  and Ruoslahti (1988)  demonstrated that 
expression of proteoglycan can inhibit the proliferation of 
Chinese hamster ovary cells. However, previously character- 
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not possess significant antiproliferative activity for SCs. Ec- 
cleston and co-workers (1989) have demonstrated that type 
I collagen matrices can decrease the rate of DNA synthesis 
in SCs. While type I collagen had partial inhibitory effects 
on SC proliferation in our assays, type I collagen was not de- 
tecled in antiproliferative  fractions of SC CM. 
The high molecular weight complex did not lose activity 
after dissociation and separation of the 55-kD activity (cf. 
Fig. 7), suggesting that the 55-kD NAP might not be active 
when complexed. It is interesting to speculate that the 55-kD 
NAP exists in a precursor form or that it might be activated 
by dissociation from an inhibitor.  Presently, limited quanti- 
fies of the 55-kD NAP have hampered detailed biochemical 
analysis, although recently we have found that adult (but not 
neonatal) sciatic nerve extracts are a rich source of antipro- 
liferative activity. This observation suggests that the NAP 
may be involved in nerve development. 
The control of SC proliferation has been most thoroughly 
studied using in vitro methods. Recently a number of mito- 
gens have been described for SCs which may act through an 
autocrine pathway including laminin,  glial maturation  fac- 
tor, and transforming growth .factor-B (Bosch et al.,  1984; 
Ratner et al.,  1986; Lim et al.,  1988; Ridley et al.,  1989). 
Autocrine  SC mitogens might  be expected to accumulate 
within the culture medium, and upon reaching a critical con- 
centration should stimulate proliferation. Other reported SC 
mitogens such as fibronectin are present in culture medium 
supplemented with serum and should also be able to stimu- 
late SC proliferation.  The present study derived from our 
recurring observation that SC responses to mitogens would 
gradually decay between medium changes (cf. Fig. 1) and in 
particular that SCs would proliferate only temporarily when 
placed in coculture with neurons (cf. Fig. 3 C). We exam- 
ined in more detail the reason for this lack of SC prolifera- 
tion in vitro and found that medium conditioned by SC cul- 
tures would inhibit the proliferation of mitogen-stimulated 
SCs. The inhibition could be virtually complete, was dose 
dependent and reversible, and was exhibited when the test 
SCs were under the influence of several mitogens (e.g., lami- 
nin,  cholera  toxin,  neurons  in coculture) thought to have 
different mechanisms of action. 
Although  several  growth  inhibitors  have  recently  been 
characterized,  little is known about their modes of action. 
Sleck and co-workers (1979) found that medium conditioned 
by contact-inhibited  (quiescent) 3T3 fibroblast cultures in- 
hibited DNA synthesis by subconfluent fibroblast cells. In 
this study SC CM was collected from dense but subconflu- 
ent cultures. However, SCs extend very long processes that 
course together, making it difficult to eliminate the possibil- 
ity that NAP is produced in response to cell-cell contact or 
culture density. This possibility seems unlikely because, in 
contrast to fibroblasts, SCs produce an antiproliferative ac- 
tivity at all densities.  Also, even at very high density, SCs 
continue to divide slowly and remain responsive to exoge- 
nous mitogens. 
Purified SCs can be established in large numbers by treat- 
ments with readily available mitogens. The cultures can be 
expanded  for  many  weeks,  and  soon  after  discontinuing 
treatment with mitogens normal growth control returns and 
the SCs revert to a nearly quiescent state. After months in 
culture,  or  even  after  being  stored  frozen,  SCs  remain 
responsive to exogenous mitogens and can proliferate and 
differentiate when in coculture with neurons (Porter et al., 
1986).  We examined  whether proliferating  SCs produced 
more or less of the antiproliferative activity compared with 
quiescent SCs. CMs from cholera toxin-stimulaled and im- 
mortalized  SCs and  from two rat  Schwannoma  cell lines 
were all found to contain antiproliferative activity for SCs. 
However, the tiler of cholera toxin-stimulated SC CM was 
<50%  of unstimulated  SC CM and immortalized  SC CM 
had even less activity (cf. Table I). Considering that the im- 
mortalization of SCs was achieved by long-lerm exposure to 
cholera toxin, it is possible that elevated cAMP results in a 
progressive decrease in production. Also, it is possible that 
mitogen  stimulation  or  proliferation  in  general  reduces 
production of the antiproliferative activity. In contradistinc- 
tion, RN22 and D6P'Zr Schwannoma cells divide even more 
rapidly than the immortalized SCs, but unlike the immortal- 
ized SC CM, Schwannoma CMs had a relatively high tiler 
of antiproliferative  activity  for  SCs.  Apparently  Schwan- 
noma  cells  can  proliferate  even  though  considerable  an- 
tiproliferative activity accumulates in their culture medium. 
The  Schwannoma  lines  were induced by carcinogens  and 
differ in several ways from the immortalized  cells.  While 
both retain many characteristics of primary SCs in culture, 
the immortalized cells can also retain the ability to differenti- 
ate and produce myelin in response to neurons (Porter et al., 
1987). 
The possibility that loss of growth control could be due to 
the loss of responsiveness to the antiproliferative activity was 
examined.  For these experiments  concentrated  serum-free 
RN22 CM was tested for its ability to inhibit the proliferation 
of cholera  toxin-stimulated  SCs,  immortalized  SCs,  and 
Schwannoma cells. Although RN22 CM completely inhib- 
iled mitogen-stimulaled  SCs,  DNA synthesis by the trans- 
formed cells was only partially inhibited (cf. Fig. 4). Similar 
results were obtained in identical experiments by using the 
purified 55-kD NAP instead of the RN22 CM. Thus, the loss 
of responsiveness to NAP could explain the loss of growth 
control by immortalized and transformed SC lines. Taken to- 
gether,  these observations suggest that mitogen-stimulaled 
SC cultures may produce somewhat less antiproliferative ac- 
tivity but remain under negative autocrine control.  Also, it 
seems plausible that immortalization (loss of normal growth 
control) by long-lerm mitogen stimulation might involve the 
selection of subclones that produce less and respond less to 
the antiproliferative activity. In this context,  subeloning of 
transformed cell lines would select for cells that are unre- 
sponsive to,  but produce,  antiproliferative  activity;  these 
cells would soon dominate over more responsive cells. Con- 
sistent with this prediction, the two clonal Schwannoma lines 
we studied are constitutive producers of NAP, yet are nearly 
unresponsive to its effects. These observations raise chal- 
lenging questions about the mechanism of autocrine growth 
regulation by NAP and its possible role in aberrant SC cell 
proliferation. Further study is required to determine whether 
autocrine growth control by NAP influences SC differentia- 
tion and their reentry  into the mitotic cycle during  nerve 
regeneration. 
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